HB 1101 prohibits insurers from denying or limiting life, disability, or long-term care insurance coverage solely because someone is a living organ donor. It specifically bans insurers from: (1) refusing coverage based on donor status, (2) requiring donors to stop donating to maintain coverage, or (3) charging higher premiums or imposing other restrictions due to donor status alone. The bill ensures that living organ donors cannot face insurance discrimination without evidence of actual increased health risk. This directly protects individuals who donate organs while alive from unfair treatment by insurance companies.
HB 1160 repeals the legal requirement for a medical marijuana oversight committee in South Dakota. The bill ends a committee that was mandated to meet twice yearly to evaluate the medical cannabis program, including patient access, dispensary operations, testing facilities, and regulatory safeguards. This change removes the committee's structure and duties, which included making recommendations to the legislature about the program's effectiveness and regulations. The repeal applies to the medical cannabis program established under existing law.
HB 1143 allows students with diabetes to possess and self-administer nasal glucagon (a medication for severe low blood sugar) on school property or at school events. It directly affects students diagnosed with diabetes who require this specific treatment. The bill requires a licensed healthcare provider’s diagnosis, written parent authorization, and a physician’s statement detailing the medication’s purpose, dosage, and administration guidelines to be kept on file at the school. Schools must maintain these documents in the student’s health record or with the school nurse. This change expands existing provisions for asthma and anaphylaxis medications to include nasal glucagon for diabetes management.
South Dakota would join the Physician Assistant Licensure Compact, allowing physician assistants (PAs) licensed in other participating states to practice in South Dakota without obtaining a separate state license. This directly affects PAs - especially active-duty military personnel and their spouses - who can use their existing license from another participating state to practice in South Dakota. The key mechanism is the "Compact Privilege," which permits PAs to provide medical services where the patient is located, while maintaining patient safety through existing state licensing board oversight. This reduces licensing barriers for PAs and improves access to medical care across state lines.
HB 1279 permits technical college employees in South Dakota to join the state health plan, directly affecting permanent staff working 20+ hours weekly at least six months yearly. The bill requires the technical college’s local education agency (LEA) to pay equivalent monthly contributions instead of the state, and removes previous restrictions preventing these employees from enrolling. Key provisions include defining "technical college employee" and ensuring LEAs cover the same cost as the state does for other plan-eligible employees. The law takes effect July 1, 2027, and applies only to technical college staff, not other state workers.
SB 220 directs South Dakota's Department of Corrections to conduct a study evaluating juvenile correctional and residential facilities. The study must examine best practices, therapeutic housing models, vocational training combined with mental health services, and staff-to-youth ratios, including inspections at three facilities outside South Dakota. The bill appropriates $50,000 from the general fund to cover study costs and requires a written report to the Legislative Research Council by September 1, 2026. This is a procedural study bill with no direct policy changes or new requirements for facilities, solely aimed at gathering information for future decisions.
HB 1043 allocates $978,294 to reimburse 12 specific rural healthcare professionals (4 family physicians, 2 physician assistants, and 6 nurse practitioners) who met requirements under §34-12G-3 for rural recruitment programs. It also allocates $370,000 to reimburse other eligible healthcare professionals meeting requirements under §34-12G-12. The funds come from the state general fund and are intended to cover costs incurred by providers who participated in designated rural recruitment initiatives. The bill declares an emergency to expedite funding, with unspent funds reverting per standard procedures.
HB 1105 prevents property owners in specific areas from using contracts or declarations to block healthcare services on commercial property. It applies to municipalities/townships under 3,000 people (per federal census) or areas officially designated as medically underserved by South Dakota’s Department of Health. The bill invalidates any contract or declaration that restricts the use of commercial property for healthcare services like clinics, diagnoses, or treatment in these areas. This directly affects property owners and developers who previously could impose such restrictions, while enabling healthcare providers to operate in underserved communities.
SB 8 allows South Dakota public schools to stock and administer epinephrine nasal spray (in addition to auto-injectors) for students experiencing severe allergic reactions (anaphylaxis) during school hours. It requires schools to adopt clear policies for storage and use, notify parents about these policies, and train designated staff (like school nurses) to recognize allergic reactions, administer the nasal spray, and provide emergency care. The bill also provides liability protection for schools and staff who follow the protocol, shielding them from ordinary negligence claims when acting in good faith during emergencies. This directly affects all public school districts, students with allergies, and school personnel authorized to respond to allergic emergencies.
HB 1068 allows South Dakota pharmacists to dispense ivermectin and hydroxychloroquine to adults 18+ based on written protocols created by physicians. These protocols must include risk assessments, drug information (indications, usage, side effects), and instructions for handling adverse events. The law shields physicians and pharmacists from liability for good-faith compliance, except in cases of gross negligence or willful misconduct. It directly affects healthcare providers who dispense these drugs and patients receiving them under this new process.
